Cambridge Investment Research Advisors’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-64,090
Closed -$955K 3633
2025
Q1
$955K Buy
64,090
+3,698
+6% +$57.9K ﹤0.01% 1903
2024
Q4
$870K Buy
60,392
+5,037
+9% +$78K ﹤0.01% 1980
2024
Q3
$877K Sell
55,355
-9,733
-15% -$153K ﹤0.01% 1945
2024
Q2
$1M Buy
65,088
+6,565
+11% +$99.5K ﹤0.01% 1776
2024
Q1
$959K Buy
58,523
+9,097
+18% +$143K ﹤0.01% 1760
2023
Q4
$724K Buy
49,426
+5,869
+13% +$81.9K ﹤0.01% 1879
2023
Q3
$628K Buy
43,557
+13,683
+46% +$213K ﹤0.01% 1905
2023
Q2
$491K Buy
29,874
+5,597
+23% +$91.2K ﹤0.01% 2146
2023
Q1
$406K Buy
24,277
+2,278
+10% +$36.7K ﹤0.01% 2241
2022
Q4
$339K Buy
21,999
+264
+1% +$4.09K ﹤0.01% 2331
2022
Q3
$325K Sell
21,735
-3,814
-15% -$63.1K ﹤0.01% 2296
2022
Q2
$420K Buy
25,549
+2,069
+9% +$35.5K ﹤0.01% 2092
2022
Q1
$471K Buy
23,480
+6,407
+38% +$133K ﹤0.01% 2154
2021
Q4
$433K Sell
17,073
-20,856
-55% -$538K ﹤0.01% 2224
2021
Q3
$1.02M Buy
37,929
+1,535
+4% +$43.9K 0.01% 1499
2021
Q2
$1.05M Buy
36,394
+3,325
+10% +$92K 0.01% 1495
2021
Q1
$870K Buy
33,069
+8,377
+34% +$238K ﹤0.01% 1527
2020
Q4
$707K Buy
24,692
+7,825
+46% +$208K ﹤0.01% 1538
2020
Q3
$402K Buy
16,867
+4,477
+36% +$103K ﹤0.01% 1745
2020
Q2
$259K Buy
+12,390
New +$244K ﹤0.01% 1998

Other funds holding BMEZ

Cambridge Investment Research Advisors's BMEZ Position: Q2 2025 in Review

Cambridge Investment Research Advisors sold out of BlackRock Health Sciences Trust II (BMEZ) in Q2 2025, closing a stake of 64,090 shares — an estimated $955K sold.

Cambridge Investment Research Advisors first reported a position in BMEZ in Q2 2020 and held it in 20 quarters. The position peaked at $1.05M in Q2 2021. 76 funds tracked by Wall St. Rank hold BMEZ as of Q2 2025.

  • Cambridge Investment Research Advisors reported no remaining BlackRock Health Sciences Trust II position as of Q2 2025 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 64,090 BlackRock Health Sciences Trust II shares in Q2 2025, an estimated $955K.
  • Cambridge Investment Research Advisors first reported a position in BlackRock Health Sciences Trust II in Q2 2020 and held it in 20 quarters.
  • Cambridge Investment Research Advisors's BlackRock Health Sciences Trust II position peaked at $1.05M in Q2 2021.
  • 76 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q2 2025.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2025, filed 31 Jul 2025.